Stefan Williams
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Stefan Williams has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
Jane E. Alty
Leeds Teaching Hospitals NHS Trust, UK; Wicking Dementia Research and Education Centre, University of Tasmania, Australia
6 shared publicationsSamuel D. Relton
Leeds Institute of Health Sciences, University of Leeds, UK
6 shared publicationsHui Fang
Loughborough University
5 shared publications- Jane Alty
Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, Australia
4 shared publications Alty Jane
University of Leeds
3 shared publications- Christopher D. Graham
The Department of Psychological Sciences & Health, University of Strathclyde, Glasgow G1 1XQ, UK
3 shared publications
Latest Publications
- Open Access
- 10 June 2024
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 463, 123089
Deep learning of Parkinson's movement from video, without human-defined measures
- 10 June 2024
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 463, 123089
Open AccessDeep learning of Parkinson's movement from video, without human-defined measures
- 28 November 2023
- Published by BMJ
- Vol. 94 (Suppl 1) , A9
Hospital healthcare utilisation by people with motor neurone disease: a one-year evaluation
We reviewed hospital healthcare events for patients under the Leeds motor neurone disease (MND) service in 2019, by retrospective analysis of hospital electronic records. There were 95 patients (63% male) with median age of 65.5 and median diagnosis duration of 1.7 years. A new diagnosis was made in 26, and 22 patients died. There were 1,722 hospital outpatient contacts (pre- or post-MND diagnosis) in 2019: 1,630 (95%) were for MND needs via 23 specialties; 1,371 (80%) via the MND multidisciplinary team. There were 501 (31%) telephone contacts, 471 (27%) face-to-face appointments, and 402 (23%) home visits. The remainder were email, text or unrecorded. There were 29 unplanned admissions amongst 20 patients with diagnosed MND resulting in 825 inpatient days. Reasons for admission included: 21 (72%) due to respiratory symptoms/infections, 4 (14%) due to mobility issues/fall, 3 (10%) due to bulbar symptoms and 1 (3%) due to a blocked gastrostomy tube. Patients with MND require high levels of care, reflecting complex needs and significant demands upon healthcare staff, patients and caregivers. This intensive healthcare utilisation highlights the importance of understanding, developing and improving MND patient pathways. Optimising such pathways could improve quality of life and save costs under current NHS pressures.
- 28 November 2023
- Published by BMJ
- Vol. 94 (Suppl 1) , A9
Hospital healthcare utilisation by people with motor neurone disease: a one-year evaluation
We reviewed hospital healthcare events for patients under the Leeds motor neurone disease (MND) service in 2019, by retrospective analysis of hospital electronic records. There were 95 patients (63% male) with median age of 65.5 and median diagnosis duration of 1.7 years. A new diagnosis was made in 26, and 22 patients died. There were 1,722 hospital outpatient contacts (pre- or post-MND diagnosis) in 2019: 1,630 (95%) were for MND needs via 23 specialties; 1,371 (80%) via the MND multidisciplinary team. There were 501 (31%) telephone contacts, 471 (27%) face-to-face appointments, and 402 (23%) home visits. The remainder were email, text or unrecorded. There were 29 unplanned admissions amongst 20 patients with diagnosed MND resulting in 825 inpatient days. Reasons for admission included: 21 (72%) due to respiratory symptoms/infections, 4 (14%) due to mobility issues/fall, 3 (10%) due to bulbar symptoms and 1 (3%) due to a blocked gastrostomy tube. Patients with MND require high levels of care, reflecting complex needs and significant demands upon healthcare staff, patients and caregivers. This intensive healthcare utilisation highlights the importance of understanding, developing and improving MND patient pathways. Optimising such pathways could improve quality of life and save costs under current NHS pressures.
- 28 November 2023
- Published by BMJ
- Vol. 94 (Suppl 1) , A78
Eyes don’t lie – opsoclonus ataxia syndrome as a first presentation of ovarian teratoma
We describe a case of a 17-year-old female with no medical history, who presented with a 5-day history of vertigo, nausea, progressive unsteadiness, and low mood. Examination showed ataxic gait, nystagmus with fast component to the right, lower limb ill-sustained clonus and withdrawn mental state. Blood tests including screening for inflammatory, metabolic, infective, autoimmune, and neoplastic disorders were negative, including negative anti-NMDA receptor antibodies. Urine toxicology was negative. MRI Brain and Spine, and EEG, were normal. During admission, she developed opsoclonus, myoclonus, titubation, and encephalopathy. Her CSF showed lymphocytosis and normal protein. CT thorax/abdomen/pelvis revealed a mature ovarian teratoma, giving a diagnosis of teratoma-related opsoclonus myoclonus ataxia syndrome. The patient underwent salpingo-oophorectomy along with immunotherapy, with good resolution of symptoms. Anti-NMDA-receptor encephalitis is a widely known paraneoplastic syndrome of ovarian teratoma in adolescents and young females. There are rising case reports in the literature of ovarian teratoma related opsoclonus myoclonus ataxia syndrome. Early treatment with surgery and immunotherapy can lead to remission.
- 28 November 2023
- Published by BMJ
- Vol. 94 (Suppl 1) , A78
Eyes don’t lie – opsoclonus ataxia syndrome as a first presentation of ovarian teratoma
We describe a case of a 17-year-old female with no medical history, who presented with a 5-day history of vertigo, nausea, progressive unsteadiness, and low mood. Examination showed ataxic gait, nystagmus with fast component to the right, lower limb ill-sustained clonus and withdrawn mental state. Blood tests including screening for inflammatory, metabolic, infective, autoimmune, and neoplastic disorders were negative, including negative anti-NMDA receptor antibodies. Urine toxicology was negative. MRI Brain and Spine, and EEG, were normal. During admission, she developed opsoclonus, myoclonus, titubation, and encephalopathy. Her CSF showed lymphocytosis and normal protein. CT thorax/abdomen/pelvis revealed a mature ovarian teratoma, giving a diagnosis of teratoma-related opsoclonus myoclonus ataxia syndrome. The patient underwent salpingo-oophorectomy along with immunotherapy, with good resolution of symptoms. Anti-NMDA-receptor encephalitis is a widely known paraneoplastic syndrome of ovarian teratoma in adolescents and young females. There are rising case reports in the literature of ovarian teratoma related opsoclonus myoclonus ataxia syndrome. Early treatment with surgery and immunotherapy can lead to remission.
- Open Access
- 17 April 2023
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 13 (4) , 525-536
Parkinsonian Hand or Clinician’s Eye? Finger Tap Bradykinesia Interrater Reliability for 21 Movement Disorder Experts
Background: Bradykinesia is considered the fundamental motor feature of Parkinson’s disease (PD). It is central to diagnosis, monitoring, and research outcomes. However, as a clinical sign determined purely by visual judgement, the reliability of humans to detect and measure bradykinesia remains unclear. Objective: To establish interrater reliability for expert neurologists assessing bradykinesia during the finger tapping test, without cues from additional examination or history. Methods: 21 movement disorder neurologists rated finger tapping bradykinesia, by Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) and Modified Bradykinesia Rating Scale (MBRS), in 133 videos of hands: 73 from 39 people with idiopathic PD, 60 from 30 healthy controls. Each neurologist rated 30 randomly-selected videos. 19 neurologists were also asked to judge whether the hand was PD or control. We calculated intraclass correlation coefficients (ICC) for absolute agreement and consistency of MDS-UPDRS ratings, using standard linear and cumulative linked mixed models. Results: There was only moderate agreement for finger tapping MDS-UPDRS between neurologists, ICC 0.53 (standard linear model) and 0.65 (cumulative linked mixed model). Among control videos, 53% were rated > 0 by MDS-UPDRS, and 24% were rated as bradykinesia by MBRS subscore combination. Neurologists correctly identified PD/control status in 70% of videos, without strictly following bradykinesia presence/absence. Conclusion: Even experts show considerable disagreement about the level of bradykinesia on finger tapping, and frequently see bradykinesia in the hands of those without neurological disease. Bradykinesia is to some extent a phenomenon in the eye of the clinician rather than simply the hand of the person with PD.
- 17 April 2023
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 13 (4) , 525-536
Open AccessParkinsonian Hand or Clinician’s Eye? Finger Tap Bradykinesia Interrater Reliability for 21 Movement Disorder Experts
Background: Bradykinesia is considered the fundamental motor feature of Parkinson’s disease (PD). It is central to diagnosis, monitoring, and research outcomes. However, as a clinical sign determined purely by visual judgement, the reliability of humans to detect and measure bradykinesia remains unclear. Objective: To establish interrater reliability for expert neurologists assessing bradykinesia during the finger tapping test, without cues from additional examination or history. Methods: 21 movement disorder neurologists rated finger tapping bradykinesia, by Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) and Modified Bradykinesia Rating Scale (MBRS), in 133 videos of hands: 73 from 39 people with idiopathic PD, 60 from 30 healthy controls. Each neurologist rated 30 randomly-selected videos. 19 neurologists were also asked to judge whether the hand was PD or control. We calculated intraclass correlation coefficients (ICC) for absolute agreement and consistency of MDS-UPDRS ratings, using standard linear and cumulative linked mixed models. Results: There was only moderate agreement for finger tapping MDS-UPDRS between neurologists, ICC 0.53 (standard linear model) and 0.65 (cumulative linked mixed model). Among control videos, 53% were rated > 0 by MDS-UPDRS, and 24% were rated as bradykinesia by MBRS subscore combination. Neurologists correctly identified PD/control status in 70% of videos, without strictly following bradykinesia presence/absence. Conclusion: Even experts show considerable disagreement about the level of bradykinesia on finger tapping, and frequently see bradykinesia in the hands of those without neurological disease. Bradykinesia is to some extent a phenomenon in the eye of the clinician rather than simply the hand of the person with PD.
- 21 June 2022
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 147, 105776
Moving towards intelligent telemedicine: Computer vision measurement of human movement
- 21 June 2022
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 147, 105776
Moving towards intelligent telemedicine: Computer vision measurement of human movement
- 27 May 2022
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 93 (6) , A85.1-A85
248 Tremor frequency can be measured using smartphone video
Textbook descriptions of tremulous disorders typically mention the tremor frequencies characteristic of particular conditions, and determination of frequency can aid diagnosis. However, current clinical practice does not involve routine accelerometry or EMG for most tremulous patients, or use of smartphone accel- erometer, and the human eye cannot accurately measure tremor frequency. 37 hand videos were recorded with smartphone camera from 5 essential tremor participants, 10 Parkin- son’s participants and 1 functional tremor participant, either showing a hand resting or held in posture. Tremor was simiultaneously measured using a commercially available accelerometer for clinical use (‘Natus Neurology’). The computing technique of ‘optical flow’ was applied to the smartphone video to measure pixel movement over time in two directions perpendicular to the long axis of the hand. Dominant frequencies were extracted from smartphone video optical flow and from clinic accelerometer data using fast Fourier transform. Bland-Altman analysis showed a mean of the difference in measurements between smartphone video (pixel optical flow) and accelerometer of 0.05 Hz (SD 0.16 Hz) with 95% confidence intervals for this mean difference of -0.26 Hz to +0.36 Hz. We demonstrate excellent agreement between our computing method for smartphone video tremor measurement and the gold standard of accelerometry. Our computing technique suggests that neu- rologists already have ‘point and press’ contactless equipment in their pocket that has the potential to augment routine clinical assessment by measuring tremor frequency. stefanwilliams@doctors.org.uk
- 27 May 2022
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 93 (6) , A85.1-A85
248 Tremor frequency can be measured using smartphone video
Textbook descriptions of tremulous disorders typically mention the tremor frequencies characteristic of particular conditions, and determination of frequency can aid diagnosis. However, current clinical practice does not involve routine accelerometry or EMG for most tremulous patients, or use of smartphone accel- erometer, and the human eye cannot accurately measure tremor frequency. 37 hand videos were recorded with smartphone camera from 5 essential tremor participants, 10 Parkin- son’s participants and 1 functional tremor participant, either showing a hand resting or held in posture. Tremor was simiultaneously measured using a commercially available accelerometer for clinical use (‘Natus Neurology’). The computing technique of ‘optical flow’ was applied to the smartphone video to measure pixel movement over time in two directions perpendicular to the long axis of the hand. Dominant frequencies were extracted from smartphone video optical flow and from clinic accelerometer data using fast Fourier transform. Bland-Altman analysis showed a mean of the difference in measurements between smartphone video (pixel optical flow) and accelerometer of 0.05 Hz (SD 0.16 Hz) with 95% confidence intervals for this mean difference of -0.26 Hz to +0.36 Hz. We demonstrate excellent agreement between our computing method for smartphone video tremor measurement and the gold standard of accelerometry. Our computing technique suggests that neu- rologists already have ‘point and press’ contactless equipment in their pocket that has the potential to augment routine clinical assessment by measuring tremor frequency. stefanwilliams@doctors.org.uk
- Open Access
- 6 April 2022
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 437, 120251
To the emergency room and back again: Circular healthcare pathways for acute functional neurological disorders
- 6 April 2022
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 437, 120251
Open AccessTo the emergency room and back again: Circular healthcare pathways for acute functional neurological disorders
- 11 November 2020
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 8 (1) , 69-75
Accuracy of Smartphone Video for Contactless Measurement of Hand Tremor Frequency
Background: Computer vision can measure movement from video without the time and access limitations of hospital accelerometry/electromyography or the requirement to hold or strap a smartphone accelerometer.Objective: To compare computer vision measurement of hand tremor frequency from smartphone video with a gold standard measure accelerometer.Methods: A total of 37 smartphone videos of hands, at rest and in posture, were recorded from 15 participants with tremor diagnoses (9 Parkinson's disease, 5 essential tremor, 1 functional tremor). Video pixel movement was measured using the computing technique of optical flow, with contemporaneous accelerometer recording. Fast Fourier transform and Bland‐Altman analysis were applied. Tremor amplitude was scored by 2 clinicians.Results: Bland‐Altman analysis of dominant tremor frequency from smartphone video compared with accelerometer showed excellent agreement: 95% limits of agreement −0.38 Hz to +0.35 Hz. In 36 of 37 videos (97%), there was <0.5 Hz difference between computer vision and accelerometer measurement. There was no significant correlation between the level of agreement and tremor amplitude.Conclusion: The study suggests a potential new, contactless point‐and‐press measure of tremor frequency within standard clinical settings, research studies, or telemedicine.
- 11 November 2020
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 8 (1) , 69-75
Accuracy of Smartphone Video for Contactless Measurement of Hand Tremor Frequency
Background: Computer vision can measure movement from video without the time and access limitations of hospital accelerometry/electromyography or the requirement to hold or strap a smartphone accelerometer.Objective: To compare computer vision measurement of hand tremor frequency from smartphone video with a gold standard measure accelerometer.Methods: A total of 37 smartphone videos of hands, at rest and in posture, were recorded from 15 participants with tremor diagnoses (9 Parkinson's disease, 5 essential tremor, 1 functional tremor). Video pixel movement was measured using the computing technique of optical flow, with contemporaneous accelerometer recording. Fast Fourier transform and Bland‐Altman analysis were applied. Tremor amplitude was scored by 2 clinicians.Results: Bland‐Altman analysis of dominant tremor frequency from smartphone video compared with accelerometer showed excellent agreement: 95% limits of agreement −0.38 Hz to +0.35 Hz. In 36 of 37 videos (97%), there was <0.5 Hz difference between computer vision and accelerometer measurement. There was no significant correlation between the level of agreement and tremor amplitude.Conclusion: The study suggests a potential new, contactless point‐and‐press measure of tremor frequency within standard clinical settings, research studies, or telemedicine.
- 1 November 2020
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 81, 101-104
Seeing the unseen: Could Eulerian video magnification aid clinician detection of subclinical Parkinson’s tremor?
- 1 November 2020
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 81, 101-104
Seeing the unseen: Could Eulerian video magnification aid clinician detection of subclinical Parkinson’s tremor?
- 1 September 2020
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 416, 117003
The discerning eye of computer vision: Can it measure Parkinson's finger tap bradykinesia?
- 1 September 2020
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 416, 117003
The discerning eye of computer vision: Can it measure Parkinson's finger tap bradykinesia?